Sei Investments Co. Increases Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sei Investments Co. boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 20.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 416,285 shares of the company's stock after acquiring an additional 71,029 shares during the quarter. Sei Investments Co. owned 0.09% of GE HealthCare Technologies worth $32,545,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Cathy Pareto & Associates Inc. bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth approximately $670,000. Principal Financial Group Inc. boosted its position in GE HealthCare Technologies by 1.9% during the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company's stock valued at $94,780,000 after buying an additional 19,010 shares during the period. Everence Capital Management Inc. grew its holdings in GE HealthCare Technologies by 118.2% in the 4th quarter. Everence Capital Management Inc. now owns 18,870 shares of the company's stock worth $1,475,000 after acquiring an additional 10,220 shares during the last quarter. Nomura Asset Management Co. Ltd. increased its position in shares of GE HealthCare Technologies by 9.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 145,996 shares of the company's stock valued at $13,702,000 after acquiring an additional 12,908 shares during the period. Finally, Apollon Wealth Management LLC raised its stake in shares of GE HealthCare Technologies by 46.5% during the fourth quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company's stock valued at $1,025,000 after acquiring an additional 4,160 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

Several research firms recently issued reports on GEHC. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their target price for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. Finally, Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $98.75.

GE HealthCare Technologies Stock Down 2.0 %

NASDAQ GEHC traded down $1.65 during trading hours on Friday, reaching $80.01. 3,189,762 shares of the company's stock traded hands, compared to its average volume of 2,933,671. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The firm has a 50-day simple moving average of $86.70 and a 200 day simple moving average of $85.87. The firm has a market cap of $36.59 billion, a PE ratio of 18.48, a PEG ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio is presently 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.